INTRODUCTION STATEMENT OF THE PROBLEM THE pharmaceutical market in India today is worth Rs.57206 crores up from Rs. 5000 crores in 1995*. It is one of the fastest growing markets with a growth rate of around 15%. India has a large number of Pharmaceutical companies which operate in an environment of high competition. The competition is even higher in a high generic market like in India where drugs are in fierce price competition. It is estimated that there are around 20‚000 pharmaceutical
Premium Physician Pharmacology Medicine
Scenario ((Projected Pharmaceutical Market‚ 2004-2009)) 2.2.3 New Product Launches underlie market growth 2.2.5 Key Opportunities 2.2.6 FDI in Indian pharma 2.2.7 Strategy and Trends 2.2.8 Research and Development 2.2.9 SWOT Analysis 2.2.10 Mergers and Acquisitions in Pharma 2.2.11 Good Opportunities for ‘big pharma’ References Chapter Three-Merger between Glaxo Wellcome Smithkline Beecham 3.1 Introduction 3.2 Merger rationale 3.2.1 Rapid advances in Science
Premium Mergers and acquisitions Pharmaceutical industry
Glenmark Pharma Private Limited Case Study Introduction * The company is headquartered in Baroda. * Mr. Ranjit Deshmukh holds the position of the Vice President. * Plants set up in Tamilnadu‚ Hyderabad and Gurgaon. * Markets bulk and cancer drugs and formulations. * Strong sales force of 700 people‚ supervised by 85 sales managers. * Salespeople have to compete with multiple competitors in different markets. * Competitors are from local manufacturers to large multinationals
Premium Management Sales Maslow's hierarchy of needs
1 Introduction Promoting industries and creating jobs‚ if successful‚ would boost economic development and thereby support state building. While politicians and bureaucrats are aware of how important industrial development is‚ they are unaware of how to facilitate it. In the international development cooperation community in developed countries and international organizations‚ the commonly accepted view until recently was that industrial policy would not work because market failures prevent industrial
Premium Pharmaceutical industry Pharmacology Generic drug
growing rapidly due to the capability of Indian players to produce cost-effective drugs with world class manufacturing facilities. Bulk drugs of all major therapeutic groups‚ requiring complicated manufacturing processes are now being produced in India. Pharma companies have developed Good Manufacturing Practices (GMP) compliant facilities for the production of different dosage forms. In addition‚ India’s long-established position as a preferred manufacturing location for multinational drug manufacturers
Premium Pharmaceutical industry Clinical trial Pharmacology
DNA QUESTION 1995: L. PETERSON/AP BIOLOGY The diagram below shows a segment of DNA with a total length of 4‚900 base pairs. The arrows indicate reaction sites for two restriction enzymes (enzyme X and enzyme Y). (A) Explain how the principles of gel electrophoresis allow for the separation of DNA fragments. (B) Describe the results you would expect from electrophoretic separation of fragments from the following treatments of the DNA segment above. Assume that the digestion
Premium
industry’s weaknesses could include high-risk business modeling‚ disengaged Board of Directors‚ dated medical equipment‚ poor branding‚ low staff morale or diseconomies of scale. * Sponsored Links * Contract Pharma Magazine Read this Months Issue - For Pharma Biopharma Outsourcing Professionals www.contractpharma.com Opportunities * The opportunities of the pharmaceutical industry’s SWOT analysis document the external industry components that provide a chance for the industry
Premium Generic drug Management Porter five forces analysis
Case: BIOCON LTD. Building a biotech powerhouse Reasons for success of Biocon Ltd. in the past: Sequential growth strategy: Biocon added businesses like enzymes‚ biopharmaceuticals‚ research services and drug development that were interlinked. Consolidation of core skills: Biocon had consolidated its core skills in enzymes (known to be the building blocks of biotech)‚ established a footprint in biopharmaceuticals (which helped generate regular cash flow) and partnered with global firms (serving
Premium Pharmaceutical industry Clinical trial Pharmacology
Public Relations Tools Press Release Since it is the most efficient method to inform the media and also one of the most effective method to announce something like Veterinary Healthcare supplements by Sun Pharmaceuticals‚ there would be press release on 28th October. Sun Pharmaceuticals decides to expand their focus and are now entering into the Veterinary healthcare sector. Media Briefing A media briefing to be held for journalists from all over India in between press release and press
Premium Newspaper Medicine Public relations
Team 1: Homework No. 1 1. I was expecting an innovative name and logo from your team. 2. A very good introduction of the industry. Note ii. The second edition of the textbook (Barney and Hesterly) is copyrighted in 2008. 3. Industry rivalry: use a note to indicate the source when you applied the number (e.g.‚ 25% of the market presence) to support your analysis. 4. Threat of substitutes: Generic brands are more likely to be considered as “competitive” products. Yes‚ CAM and alternative
Premium Generic drug Pharmaceutical industry Alternative medicine